In their article entitled “Cross-Market Hospital Mergers: A Holistic Approach,” Greg Vistnes and Yianis Sarafidis analyze the question of whether cross-market hospital mergers can reduce competition and, if so, certain circumstances that may make that more likely. To read the article, click the link below.
What’s 340B? An economist’s view of the recent wave of 340B litigation
But this change has led to complex relationships among pharmaceutical manufacturers, hospitals, pharmacies, and third-party administrators, increasing...